Shankar Musunuri sold $166k of OCGN
Chief Executive Officer at Ocugen, Inc.. 100,000 shares at an average of $1.66, traded Oct 14, 2022, filed Oct 14, 2022.
Score components
- +25RoleCEO
- +11Trade size$166k at market
- +5Share of holdings soldSold 12% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-22-020804, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 14, 2022 | MOption exercise Common Stock | +100,000 | $0.51 | $51k | 852,540 | Oct 14, 2022 |
| Oct 14, 2022 | SOpen-market sale Common Stock10b5-1 | -100,000 | $1.66 | $166k | 752,540 | Oct 14, 2022 |
| Oct 14, 2022 | MOption exercise Option (Right to Buy)derivative | -100,000 | $0.00 | $0 | 522,352 | Oct 14, 2022 |
Related signals
Other insiders at Ocugen, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 21, 2026 | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $500k 525,991 shares | -12% | |
| 29Weak | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $589k 525,991 shares | -11% | |
| 35Weak | OCGNbuy Ocugen, Inc. | Treerita Essalima Johnson-Greene Chief Financial Officer | $26k 21,000 shares | +4% | |
| 31Weak | Ocugen, Inc. | Prabhavathi Fernandes director | $9,095 10,000 shares | - | |
| 33Weak | Ocugen, Inc. | Kirsten Castillo director | $23k 25,000 shares | +50% | |
| 6Weak | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $137k 95,809 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.